|
1.
|
|
10 p, 1.5 MB |
LiverScreen project : study protocol for screening for liver fibrosis in the general population in European countries
/
Graupera, Isabel (Universitat de Barcelona) ;
Thiele, Maja (Odense University Hospital, and Institute for Clinical Research, University of Southern Denmark Odense. Centre for Liver Research, Department of Gastroenterology and Hepatology) ;
Ma, Ann T. (Universitat de Barcelona) ;
Serra-Burriel, Miquel (Epidemiology, Statistics, and Prevention Institute, University of Zurich) ;
Pich, Judit (Clinical Trial Unit, Hospital Clínic) ;
Fabrellas, Núria (Universitat de Barcelona) ;
Caballería, Llorenç (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ;
de Knegt, Robert J. (Erasmus MC University Medical Centre. Department of Gastroenterology and Hepatology) ;
Grgurevic, Ivica (University Hospital Dubrava, University of Zagreb School of Medicine and Faculty of Pharmacy and Biochemistry. Department of Gastroenterology, Hepatology and Clinical Nutrition) ;
Reichert, Mathias (Saarland University Medical Center. Department of Medicine II) ;
Roulot, Dominique (AP-HP, Université Paris 13. Unité d'Hépatologie, Hôpital Avicenne) ;
Schattenberg, Jörn M. (University Medical Centre of the Johannes Gutenberg. Metabolic Liver Research Program, Department of Internal Medicine I) ;
Pericàs, Juan M (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Angeli, Paolo (University Hospital of Padova (Pàdua, Itàlia)) ;
Tsochatzis, Emmanuel A. (University College of London) ;
Guha, Indra Neil (NIHR Nottingham Biomedical Research University Mainz Centre, Nottingham University Hospitals NHS Trust and the University of Nottingham) ;
Garcia-Retortillo, M (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Morillas, Rosa Maria (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Hernández, Rosario (Institut Catala de la Salut (ICS). BCN. Ambit d'Atencio Primaria) ;
Hoyo, Jordi (Institut Catala de la Salut (ICS). BCN. Ambit d'Atencio Primaria) ;
Fuentes, Matilde (Institut Catala de la Salut (ICS). BCN. Ambit d'Atencio Primaria) ;
Madir, Anita (University Hospital Dubrava, University of Zagreb School of Medicine and Faculty of Pharmacy and Biochemistry. Department of Gastroenterology, Hepatology and Clinical Nutrition) ;
Juanola, Adrià (Universitat de Barcelona) ;
Soria, Anna (Universitat de Barcelona) ;
Juan, Marta (Clinical Trial Unit, Hospital Clínic) ;
Carol, Marta (Universitat de Barcelona) ;
Díaz, Alba (Department of Pathology. Centre of Biomedical Diagnosis. Hospital Cínic, Barcelona, Spain) ;
Detlefsen, Sönke (Odense University Hospital (Dinamarca)) ;
Torán Montserrat, Pere (Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Metropolitana Nord, IDIAP Jordi Gol, ICS Institut Català de la Salut. Unitat de Suport a la Recerca Metropolitana Nord) ;
Fournier, Céline (Echosens, Paris, France) ;
Llorca, Anne (Echosens, Paris, France) ;
Newsome, Phillip N. (National Institute for Health Research Biomedical Research Centre at University Hospitals Birmingham NHS Foundation Trust and the University of Birmingham) ;
Manns, Michael (Hannover Medical School) ;
de Koning, Harry J. (Erasmus University Medical Center. Department of Public Health) ;
Serra-Burriel, Feliu (Barcelona Supercomputing Center) ;
Cucchietti, Fernando (Barcelona Supercomputing Center) ;
Arslanow, Anita (University Medical Centre of the Johannes Gutenberg. Metabolic Liver Research Program, Department of Internal Medicine I) ;
Korenjak, Marko (European Liver Patients' Association, Brussels, Belgium) ;
van Kleef, Laurens (Erasmus MC University Medical Centre. Department of Gastroenterology and Hepatology) ;
Falcó, Josep Lluis (GENESIS Biomed (Barcelona, Catalunya)) ;
Kamath, Patrick S. (Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine and Science) ;
Karlsen, Tom H. (Oslo University hospital) ;
Castera, Laurent (Université de Paris. Department of Hepatology, Hôpital Beaujon, Assistance Publique-Hôpitaux de Paris, Clichy) ;
Lammert, Frank (Hannover Medical School (MHH)) ;
Krag, Aleksander (Odense University Hospital, and Institute for Clinical Research, University of Southern Denmark Odense. Centre for Liver Research, Department of Gastroenterology and Hepatology) ;
Ginès, Pere (Universitat de Barcelona) ;
Universitat Autònoma de Barcelona.
Departament de Medicina
The development of liver cirrhosis is usually an asymptomatic process until late stages when complications occur. The potential reversibility of the disease is dependent on early diagnosis of liver fibrosis and timely targeted treatment. [...]
2022 -  10.1186/s12889-022-13724-6
BMC public health, Vol. 22 (july 2022)
|
|
|
2.
|
|
10 p, 1.1 MB |
Biochemical assessment of metabolic associated fatty liver disease
/
Guerra-Ruiz, Armando R. (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ;
Casals, Gregori (Hospital Clínic i Provincial de Barcelona) ;
Iruzubieta, Paula (Instituto de Investigación Marqués de Valdecilla) ;
Lalana, Marta (Hospital de Barbastro) ;
Leis, Alba (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
López, Rosa María (Hospital Universitari Vall d'Hebron) ;
Crespo García, Javier (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ;
Morales Ruiz, Manuel (Hospital Clínic i Provincial de Barcelona) ;
Universitat Autònoma de Barcelona
Metabolic-associated fatty liver disease (MAFLD) is defined as fat accumulation in the liver in the presence of metabolic alterations. This disorder is generally asymptomatic and may progress to severe liver disease, which are linked to inflammation and/or fibrosis. [...]
2021 - 10.1515/almed-2021-0009
Advances in Laboratory Medicine, Vol. 2 (march 2021) , p. 199-208
|
|
|
3.
|
|
10 p, 823.8 KB |
Abdominal obesity and dsyglycemia are risk factors for liver fibrosis progression in NAFLD subjects : A population-based study
/
Julián, María Teresa (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Ballesta Purroy, Sílvia (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Pera, Guillem (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ;
Pérez-Montes de Oca, Alejandra (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Soldevila i Madorell, Berta (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Caballería, Llorenç (Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas) ;
Morillas Cunill, Rosa Ma (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Expósito, Carmen (Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas) ;
Martínez-Escudé, Alba (Institut Català de la Salut. Centre d'Atenció Primària La Llagosta) ;
Puig Domingo, Manuel (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Franch-Nadal, Josep (Institut Català de la Salut. Centre d'Atenció Primària Raval Sud (Barcelona, catalunya)) ;
Torán, Pere (Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas) ;
Cusi, Kenneth (University of Florida) ;
Julve i Gil, Josep (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ;
Mauricio Puente, Dídac (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Alonso Pedrol, Núria (Universitat Autònoma de Barcelona. Departament de Medicina)
To investigate longitudinal changes in the liver stiffness measurement (LSM) in the general adult population without known liver disease and to describe its association with metabolic risk factors, with a special focus on subjects with non-alcoholic fatty liver disease (NAFLD) and dysglycemia. [...]
2023 - 10.3389/fendo.2022.1051958
Frontiers in Endocrinology, Vol. 13 (january 2023)
|
|
|
4.
|
|
10 p, 584.0 KB |
Prevalence estimation of significant fibrosis because of NASH in Spain combining transient elastography and histology
/
Calleja, Jose Luis (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ;
Rivera-Esteban, Jesús (Universitat Autònoma de Barcelona) ;
Aller, Rocio (Universidad de Valladolid. BioCritic) ;
Hernández-Conde, Marta (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ;
Abad, Javier (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ;
Pericàs, Juan M. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Benito, Hugo G. (Instituto de Estudios de Ciencias de la Salud de Castilla y León) ;
Serra, Miguel A. (Universitat de València) ;
Escudero, Amparo (Universitat de València) ;
Ampuero, Javier (Universidad de Sevilla) ;
Lucena, Ana (Universidad de Sevilla) ;
Sánchez, Yolanda (Universidad de Sevilla) ;
Arias-Loste, Maria T. (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ;
Iruzubieta, Paula (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ;
Romero-Gómez, Manuel (Universidad de Sevilla) ;
Augustin Recio, Salvador (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Crespo García, Javier (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria))
Background & Aims: Non-alcoholic fatty liver disease (NAFLD) has become a major public health problem, but the prevalence of fibrosis associated with non-alcoholic steatohepatitis (NASH) is largely unknown in the general population. [...]
2022 - 10.1111/liv.15323
Liver International, 2022
|
|
|
5.
|
|
15 p, 1023.9 KB |
TSH Levels as an Independent Risk Factor for NAFLD and Liver Fibrosis in the General Population
/
Martínez-Escudé, Alba (Institut Català de la Salut. Centre d'Atenció Primària La Llagosta) ;
Pera, Guillem (Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas) ;
Costa-Garrido, Anna (Universitat Autònoma de Barcelona) ;
Rodríguez, Lluís (Institut Català de la Salut) ;
Arteaga, Ingrid (Institut Català de la Salut) ;
Expósito, Carmen (Institut Català de la Salut. Centre d'Atenció primària Badia del Vallès) ;
Torán Montserrat, Pere (Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas) ;
Caballería, Llorenç (Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas)
Thyroid hormones may be a risk factor for the development of non-alcoholic fatty liver disease (NAFLD) and its progression to liver fibrosis. The aim of this study is to investigate the relationship between thyroid stimulating hormone (TSH) levels, NAFLD, and liver fibrosis in the general population. [...]
2021 - 10.3390/jcm10132907
Journal of clinical medicine, Vol. 10, Issue 13 (June 2021) , art. 2907
|
|
|
6.
|
|
14 p, 1.1 MB |
Elastography is unable to exclude cirrhosis after sustained virological response in HCV-infected patients with advanced chronic liver disease
/
Broquetas, Teresa (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Herruzo-Pino, Paula (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Mariño, Zoe (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Naranjo-Hans, Dolores (Hospital del Mar (Barcelona, Catalunya)) ;
Vergara, Mercedes (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Morillas Cunill, Rosa Ma (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Forns, Xavier (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Carrión Rodríguez, José Antonio (Universitat Autònoma de Barcelona. Departament de Medicina)
Background: Liver fibrosis and transient elastography (TE) correlation in hepatitis C virus (HCV)-infected patients with compensated advanced chronic liver disease (cACLD) after the sustained virological response (SVR) is unknown. [...]
2021 - 10.1111/liv.15058
Liver International, Vol. 41 Núm. 11 (november 2021) , p. 2733-2746
|
|
|
7.
|
|
|
8.
|
|
8 p, 251.6 KB |
Chronic hepatitis D associated with worse patient-reported outcomes than chronic hepatitis B
/
Buti, Maria (Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas) ;
Stepanova, Maria (Center for Outcomes Research in Liver Disease, Washington, DC, USA) ;
Palom, Adriana (Hospital Universitari Vall d'Hebron) ;
Riveiro Barciela, Mar (Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas) ;
Nader, Fatema (Center for Outcomes Research in Liver Disease, Washington) ;
Roade, Luisa (Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas) ;
Esteban, Rafael (Esteban Mur) (Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas) ;
Younossi, Zobair (Betty and Guy Beatty Center for Integrated Research) ;
Universitat Autònoma de Barcelona
Health-related quality of life (HRQoL) determined by patient-reported outcomes (PROs) is impaired in chronic hepatitis B (CHB) and C patients, but there are no data regarding patients with chronic hepatitis D (CHD). [...]
2021 - 10.1016/j.jhepr.2021.100280
JHEP Reports, Vol. 3 (march 2021)
|
|
|
9.
|
|
8 p, 518.6 KB |
Liver fibrosis and accelerated immune dysfunction (immunosenescence) among HIV-infected Russians with heavy alcohol consumption - an observational cross-sectional study
/
So-Armah, Kaku (Boston University School of Medicine. Department of Medicine) ;
Freiberg, Matthew (Vanderbilt University School of Medicine; Nashville Veterans Affairs Medical Center, Tennessee Valley Healthcare System. Department of Medicine) ;
Cheng, Debbie (Boston University School of Public Health. Department of Biostatistics) ;
Lim, Joseph K. (Yale University School of Medicine. Department of Internal Medicine) ;
Gnatienko, Natalia (Boston Medical Center. Department of Medicine) ;
Patts, Gregory (Boston University School of Public Health. Department of Biostatistics and Data Coordinating Center) ;
Doyle, Margaret (University of Vermont. Department of Pathology and Laboratory Medicine) ;
Fuster, Daniel (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Lioznov, Dmitry (First Pavlov State Medical University. Department of Infectious Diseases and Epidemiology, Smorodintsev Research Institute of Influenza) ;
Krupitsky, Evgeny (First Pavlov State Medical University, V. M. Bekhterev National Research Medical Center for Psychiatry and Neurology, St. Petersburg, Russia) ;
Samet, Jeffrey (Boston University School of Medicine. Department of Medicine, Boston Medical Center) ;
Universitat Autònoma de Barcelona
The multifactorial mechanisms driving negative health outcomes among risky drinkers with HIV may include immunosenescence. Immunosenescence, aging of the immune system, may be accentuated in HIV and leads to poor outcomes. [...]
2019 - 10.1186/s12876-019-1136-4
BMC Gastroenterology, Vol. 20 (december 2019)
|
|
visitant ::
identificació
alerta personal via correu electrònic o subscribiu-vos al 
canal RSS.
